title: Effect of intravenous infusion of NIK-716 in anesthetized pediatric patients.
abstract: NIK-716 is a maintenance fluid based on the new concept of containing acetate as a base source and 5% glucose as an energy source. It was administered to pediatric patients under general anesthesia for less invasive surgical operations, and its efficacy was investigated by performing blood chemistry examination and urinalysis before and after administration. For efficacy assessment, the three items selected as efficacy parameters, i) the replacement and maintenance of water (assessment of hydration and urine output); ii) the maintenance of serum electrolytes (Na and K); and iii) the utilization of glucose (blood glucose and urinary glucose), were evaluated based on the results of laboratory examination (hematology, blood chemistry and urinalysis), and overall improvement was rated on the basis of total scores of these assessment items. No adverse events or abnormal laboratory values attributable to the maintenance fluid were observed in any of the 25 children administered NIK-716. In an overall improvement rating, NIK-716 proved markedly effective or effective in 79.2% of the 24 children evaluated. The overall safety rating was judged as 'no problem' in all 25 children. These findings suggest that NIK-716 is a useful and safe maintenance fluid that can be administered to pediatric patients during the course of surgery.
authors.affiliation: Department of Anesthesia and ICU, National Center for Child Health and Development, Tokyo, Japan. miyasaka-k@ncchd.go.jp
authors.forename: K
authors.initials: K
authors.lastname: Miyasaka
authors.forename: Y
authors.initials: Y
authors.lastname: Kondo
authors.forename: S
authors.initials: S
authors.lastname: Asahara
authors.forename: T
authors.initials: T
authors.lastname: Tamura
authors.forename: Y
authors.initials: Y
authors.lastname: Suzuki
mesh_terms: D000293:Adolescent; D000768:Anesthesia, General / Q000379:methods*; D002648:Child; D002675:Child, Preschool; D005260:Female; D005440:Fluid Therapy / Q000009:adverse effects* / Q000379:methods*; D006801:Humans; D007223:Infant; D007262:Infusions, Intravenous / Q000009:adverse effects / Q000379:methods; D007430:Intraoperative Care / Q000009:adverse effects / Q000379:methods; D008297:Male; D008991:Monitoring, Physiologic / Q000379:methods; D015532:Rehydration Solutions / Q000009:adverse effects / Q000627:therapeutic use; D013514:Surgical Procedures, Operative / Q000379:methods; D014882:Water-Electrolyte Balance / Q000187:drug effects / Q000502:physiology
chemical_list: D015532:Rehydration Solutions